Glomerulonephritis News and Research

RSS
Psoriasis link with autoimmune diseases underscored

Psoriasis link with autoimmune diseases underscored

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Oak Pharmaceuticals acquires three Lundbeck hospital-based injectables

Oak Pharmaceuticals acquires three Lundbeck hospital-based injectables

Demand for kidney transplant and dialysis increases due to diabetes prevalence

Demand for kidney transplant and dialysis increases due to diabetes prevalence

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

USPTO grants Taligen patent for TT30 lead product candidate

USPTO grants Taligen patent for TT30 lead product candidate

Omeros net loss for second-quarter 2010 increases to $7.8 million

Omeros net loss for second-quarter 2010 increases to $7.8 million

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Japanese Patent granted for Pharmalink AB's Nefecon

Japanese Patent granted for Pharmalink AB's Nefecon

NovaBay begins clinical studies for treating impetigo skin infection

NovaBay begins clinical studies for treating impetigo skin infection

Five Clinical Research Units established

Five Clinical Research Units established

7-step guide to understanding tonsils and strep

7-step guide to understanding tonsils and strep

Bioniche granted additional patent for mycobacterial cell wall technology

Bioniche granted additional patent for mycobacterial cell wall technology

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus